Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Magen BioSciences gets $15.4mm with its Series A round

Executive Summary

Magen BioSciences (dermatology treatments) has closed its $15.4mm Series A venture round. Highland Capital led the financing and was joined by new backers IDG Ventures and QVT Financial and current shareholders Alexandria Real Estate, Arch Venture Partners, Lux Capital, TVM Capital, and Venrock Associates.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register